Treatment of children with Osteogenesis imperfecta in Estonia

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 4, 2003, Pages 452-455

  Maasalu, K ^a   Haviko, T ^a   Märtson, Aare ^a  

^a TARTU UNIVERSITY CLINICS   (Estonia)

Author keywords

Alendronate; Bone mineral density; Fractures; Oral bisphosphonate; Osteogenesis imperfecta

Indexed keywords

ALENDRONIC ACID; CALCITRIOL; CALCIUM CHANNEL STIMULATING AGENT;

ADOLESCENT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE RADIOGRAPHY; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTONIA; FEMALE; FOLLOW UP; FRACTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; ORTHOPEDIC SURGERY; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRABECULAR BONE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; CHILD; DRUG COMBINATION; DRUG EFFECT; ORAL DRUG ADMINISTRATION; OUTCOME ASSESSMENT; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME;

ADMINISTRATION, ORAL; ADOLESCENT; ALENDRONATE; BONE DENSITY; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ESTONIA; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; INFANT; MALE; OSTEOGENESIS IMPERFECTA; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0042878485     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2003.tb00577.x     Document Type: Article

References (16)

1. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101-16.
2. Freemont J. The pathology of osteogenesis imperfecta. J Clin Pathol 1996; 49: 8-9.
3. Byers PH. Osteogenesis imperfecta. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley-Liss; 1993: 317-50.
4. Lund AM, Schwartz M, Raghunath M, Steinman B, Skovby F. Gly802Asp substitution in the pro α2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism. Eur J Hum Genet 1996; 4: 39-45.
5. Lund AM, Molgaard C, Müller J, Skovby F. Bone mineral content and collagen defects in osteogenesis imperfecta. Acta Pæediatr 1999; 88: 1083-8.
6. Wilkinson JM, Scott BW, Clarke AM, Bell MJ. Surgical stabilization of the lower limb in osteogenesis imperfecta using the Sheffield telescopis intramedullary rod system. J Bone Joint Surg Br 1998; 80-B: 999-1004.
7. Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tato L. Osteogenesis imperfecta: practical treatment guidelines. Paediatr Drugs 2000; 2: 456-88.
8. Srivastava T, Alon US. Bisphosphonates: from grandparents to grandchildren. Clin Pediatr (Phila) 1999; 38: 687-702.
9. Devogelaer JP. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Curr Opin Rheumatol 2000; 12: 331-5.
10. Åström E, Söderhäll S. Beneficial effect of bisphosphonates during five years of treatment of severe osteogenesis imperfecta. Acta Paëdiatr 1998; 87: 64-8.
11. Shaw NJ. Bisphosphonates in osteogenesis imperfecta. Arch Dis Child 1997; 77: 92-3.
12. Glorieux F, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998; 339: 947-52.
13. Canalis E. Regulation of bone remodeling. In: Murray JF, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Lippincott-Raven (3rd ed.); 1996: 29-34.
14. Dambacher MA, Schacht E. Osteoporosis and active vitamin D metabolites. Basle: EULAR Publishers; 1996.
15. Holick MF. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Murray JF, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Lippincott-Raven (3rd ed.); 1996: 74-81.
16. Cole WG. Surgery in Osteogenesis imperfecta. Connect Tissue Res 1995; 31: 27-9